Clinical Effect of MiboFlo in Dry Eye Patients

Clinical Effect of MiboFlo in Dry Eye Patients

The aim of this prospective study is to compare the changes between the patients receiving traditional treatment and the patients with MiBoFlo, evaluating the effectiveness of MiBoFlo.

The MiBoFlo Thermoflo uses a proprietary thermoelectric heat pump to help meibum maximize liquefaction, improving the preservation and function of the tear film's evaporative component. It supplies continuous controlled heat to the outer skin of the eyelids, absorbing deep into the tissue and breaks down the hardened oils in the meibomian glands. We are trying to find a effective, safe and economical therapy for dry eye patients.

Inclusion Criteria:

• 18 years of age of older;
• Meet the diagnostic criteria for dry eye developed by DEWS II: OSDI score≥15 points, TBUT≤10 minutes;
• Meet the signs of meibomian gland dysfunction

Exclusion Criteria:

• Had skin allergies or inflammation;
• Had active ocular infection or inflammation;
• Had history of ocular surgery, eyelid surgery or neurological paralysis within 6 months;
• Had history of systemic disease affecting ocular surface function, such as Stevens-Johnson syndrome, Sjögren syndrome etc.